Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $598.95 Average Target Price from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have earned a consensus recommendation of “Moderate Buy” from the twenty ratings firms that are covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $598.95.

ISRG has been the subject of several research analyst reports. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Finally, Royal Bank of Canada decreased their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,044 shares of company stock worth $17,070,433 in the last quarter. Company insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of the business. CenterBook Partners LP grew its position in shares of Intuitive Surgical by 966.0% during the first quarter. CenterBook Partners LP now owns 5,511 shares of the medical equipment provider’s stock worth $2,729,000 after buying an additional 4,994 shares in the last quarter. Headlands Technologies LLC purchased a new stake in Intuitive Surgical in the first quarter valued at approximately $14,325,000. Waycross Partners LLC raised its stake in shares of Intuitive Surgical by 22.7% during the first quarter. Waycross Partners LLC now owns 50,220 shares of the medical equipment provider’s stock worth $24,872,000 after purchasing an additional 9,277 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Intuitive Surgical by 2.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,385,472 shares of the medical equipment provider’s stock worth $1,181,453,000 after purchasing an additional 67,803 shares during the last quarter. Finally, ASR Vermogensbeheer N.V. purchased a new stake in shares of Intuitive Surgical during the first quarter worth approximately $12,119,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.3%

Shares of ISRG stock opened at $536.55 on Wednesday. The stock has a market capitalization of $192.31 billion, a P/E ratio of 83.71, a PEG ratio of 5.85 and a beta of 1.70. The firm’s 50 day moving average is $500.93 and its 200 day moving average is $535.03. Intuitive Surgical has a 12 month low of $379.67 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 EPS. On average, equities analysts predict that Intuitive Surgical will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.